NCT03427541Unknown不适用
A Multi-centre Real-world Non-interventional Observational Study to Explore Prognoses of the Patients With Non-small Cell Lung Cancer Complicated With Oligometastases
Tang-Du Hospital10 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2017年12月31日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 1,000
- 试验地点
- 10
- 主要终点
- Overall survival
研究概览
简要总结
An observational study to explore prognoses and clinical treatments of the patients with non-small cell lung cancer complicated with oligometastases
详细描述
A multi-centre real-world non-interventional observational study to explore prognoses and clinical treatments of the patients with non-small lung cancer complicated with oligometastases
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Pathologically diagnosed patients with non-small cell lung cancer;
- •Tumor metastases in one organ (no more than 3 metastases);
排除标准
- •Patients with intrapulmonary metastases or multiple primary tumors;
- •Patients with pleural dissemination or invasion of extrapulmonary organs;
- •Patients with supraclavicular lymph node metastasis;
- •Patients with systematic diseases that would influence patient survivals;
- •Patients with no records for visits;
结局指标
主要结局
Overall survival
时间窗: 2014 - 2017
Overall survival
次要结局
- Disease-free survival(2014 - 2017)
研究者
Zhang Helong
Professor
Tang-Du Hospital
研究点 (10)
Loading locations...
相似试验
进行中（未招募）
不适用
An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With AlectinibNSCLCNCT04764188Hoffmann-La Roche800
已完成
不适用
A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC PatientsNon-small Cell Lung CancerNCT03429673China-Japan Friendship Hospital10,885
Unknown
不适用
A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine FibroidsUterine FibroidsNCT01635452PregLem SA1,500
已完成
不适用
Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)Renal Cell CarcinomaNCT05650164Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany171
已完成
不适用
A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in GreeceAdvanced Soft Tissue SarcomaNCT02618122Genesis Pharma S.A.63